According to FutureWise analysis the market for single-use bioprocessing in 2023 is US$ 11.95 billion, and is expected to reach US$ 53.9 billion by 2031 at a CAGR of 20.70%.
Single-use bioprocessing, also called disposables, refers to pharmaceutical products and solutions made to be used once and then discarded. Among the most commonly used single-use bioprocessing products are media bags, containers, filtration assemblies, disposable bioreactors, disposable mixers, tubes, connectors, and samplers. In addition to monoclonal antibodies and vaccines, these products are commonly used in the cultivation of plant cells and in the production of cell therapies. The devices are also used by biopharmaceutical companies and life science research organizations in order to increase productivity and to reduce cross-contamination risk.
For the research and manufacturing of pharmaceutical goods customised medicine, and others, single-use bioprocessing uses disposable technologies. During the development of medications and the manufacturing of various biopharmaceuticals, the use of single-use bioprocessing products has increased significantly. This invention has changed both the upstream and downstream processes of medication manufacture, making them faster, easier, and less expensive. Single-use bioprocessing systems are biopharmaceutical production (bioprocessing) systems. Plastic components that have been sterilised and sealed by gamma irradiation are frequently used in single-use bioprocessing systems. Furthermore, because of the advantages, government regulatory agencies are increasingly using single-use bioprocessing systems. The Therapeutic Goods Administration (TGA) of Australia, for example, permits the use of single-use bioprocessing systems in buffer preparation, mixing, and other upstream processes. Aside from that, TGA recommended GMP regulations for filters and other single-use bioprocessing equipment. Because of the increased need for biologics, the global Single-Use Bioprocessing Market is expected to rise. During the development stages of medications and the manufacturing of various biopharmaceuticals, the use of Single-Use Bioprocessing Market goods has increased significantly. The surge in demand for biopharmaceuticals, the rise in acceptance of disposable technologies, the minimal risk of product cross-contamination attributable to SUB technologies, and the need for less floor space are all factors driving the expansion of the single-use bioprocessing market. However, challenges like extractability and leachability, as well as strict restrictions governing the use of disposable systems in the biopharmaceutical industry, are impeding the market's growth. Furthermore, monoclonal antibodies (mAb) are produced using single-use bioprocessing methods, hence this sector dominates the worldwide single-use bioprocessing market.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Single-use Bioprocessing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Single-use Bioprocessing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.